- Previous Close
0.7420 - Open
0.7420 - Bid 0.7280 x --
- Ask 0.7400 x --
- Day's Range
0.7260 - 0.7420 - 52 Week Range
0.6600 - 0.9100 - Volume
8,669 - Avg. Volume
29,637 - Market Cap (intraday)
729.172M - Beta (5Y Monthly) 0.32
- PE Ratio (TTM)
10.57 - EPS (TTM)
0.0700 - Earnings Date --
- Forward Dividend & Yield 0.03 (4.13%)
- Ex-Dividend Date Aug 20, 2024
- 1y Target Est
--
Biofarm S.A. engages in the manufacture and sale of medicines in Romania. The company offers a portfolio of products covering therapeutic areas, such as antiallergics, cardiovascular and circulatory, analgesics and antipyretics, dermatology, digestive and metabolic, endocrine, genitourinary, multivitamins, ophthalmology, musculoskeletal, respiratory and ENT, and neurology. It provides prescription and non-prescription medicines, food supplements, medical devices, cosmetics, and other products. The company also exports its products in Azerbaijan, Albania, Georgia, Iraq, Kyrgyzstan, Hungary, and Republic of Moldova. Biofarm S.A. was incorporated in 1921 and is headquartered in Bucharest, Romania.
www.biofarm.ro378
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: BIO.RO
View MorePerformance Overview: BIO.RO
Trailing total returns as of 12/12/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BIO.RO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BIO.RO
View MoreValuation Measures
Market Cap
731.14M
Enterprise Value
599.97M
Trailing P/E
9.95
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.59
Price/Book (mrq)
1.53
Enterprise Value/Revenue
2.12
Enterprise Value/EBITDA
5.67
Financial Highlights
Profitability and Income Statement
Profit Margin
26.57%
Return on Assets (ttm)
8.29%
Return on Equity (ttm)
16.28%
Revenue (ttm)
259.28M
Net Income Avi to Common (ttm)
68.89M
Diluted EPS (ttm)
0.0700
Balance Sheet and Cash Flow
Total Cash (mrq)
132.08M
Total Debt/Equity (mrq)
0.20%
Levered Free Cash Flow (ttm)
20.99M